ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Scientists Immunize A Healthy BMT Donor Against Myeloma

May 5, 1995

Publications: The Cigarette Papers Available On the Web

September 27, 1996

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

In Brief: More Money, Not Reorganization, Is Needed For Clinical Research, Paul Carbone Argues

November 10, 1978